Pharmacological protection of the myocardium with reamberin in coronary artery bypass grafting in patients with postinfarction angina

  • Authors: Sidorenko G.I.1, Gelis L.G.1, Medvedeva E.A.1, Ostrovskiy Y.P.1, Lazareva I.V.1, Sevruk T.V.1, Shibeko N.A.1, Petrov Y.P.1, Sidorenko GI2, Gelis LG2, Medvedeva EA2, Ostrovsky Y.P2, Lazareva IV2, Sevruk TV2, Shibeko NA2, Petrov Y.P2
  • Affiliations:
    1. Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus
  • Issue: Vol 83, No 9 (2011)
  • Pages: 35-40
  • Section: Editorial
  • URL: https://ter-arkhiv.ru/0040-3660/article/view/30909
  • Cite item

Abstract


Aim. To assess efficacy of reamberin in preoperative preparation and after coronary bypass (CB) in patients with macrofocal myocardial infarction (MI) complicated with postinfarction angina.
Material and methods. A total of 45 patients with Q-positive MI complicated with postinfarction angina pectoris entered the trial. The study group consisted of 20 (44.4%) patients given 200-400 ml injections of 1.5% reamberin solution for 3 days before coronary artery bypass grafting (CABG) and 3-5 days after it. The control group consisted of 25 (55.6%) patients given basic therapy without cardioprotection. ECTG-60, echocardiography, CM-ECG, laboratory tests were made before CABG. CABG was made in conditions of artificial blood circulation in all the patients.
Results. Clinical stabilization was observed after direct myocardial revascularization in hospitalized 25 (100%) patients of the study group and 22 (88%) patients of the control group. Early postoperative acute cardiac failure (ACF) developed in 3 (12%) patients from the study group and 9 (36%) from the control group (p = 0.04), arrhythmia occurred in 2(8%) and 8(32%) patients, respectively (p = 0.03). Two (8%) control patients died in early postoperative period from acute cardiac failure. Perioperative MI occurred in 2(8%) control patients. After 12 months of the follow-up, patients of the study group had no recurrent angina pectoris, while among the controls 4(16%) patients had recurrent angina of FC III. After surgical intervention at discharge and 12 months after treatment patients of both groups improved systolic and diastolic functions of the left ventricle. Normalization of the diastolic function was registered in 80% patients of the study group (p < 0.001) and in 44% from the control group (p < 0.001) after 1 year follow-up.
Conclusion. Reamberin reduces the number of postoperative complications, ischemic damage to the myocardium, significantly improves systolic and diastolic functions of the left ventricle.

About the authors

Georgiy Ivanovich Sidorenko

Lyudmila Grigor'evna Gelis

Elena Aleksandrovna Medvedeva

Email: elena-samonina@yandex.ru

Yuriy Petrovich Ostrovskiy

Irina Valentinovna Lazareva

Tat'yana Vasil'evna Sevruk

Natal'ya Aleksandrovna Shibeko

Yuriy Petrovich Petrov

G I Sidorenko

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

L G Gelis

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

E A Medvedeva

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

Yu P Ostrovsky

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

I V Lazareva

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

T V Sevruk

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

N A Shibeko

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

Yu P Petrov

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus

References

  1. Бокерия Л. А., Маликов В. Е., Сигаев И. Ю. и др. Системы энергетического обеспечения, ПОЛ и лизосомальных ферментов при трансмиокардиальной лазерной реваскуляризации и ее сочетании с аортокоронарным шунтированием. Бюл. экспер. биол. 2002; прил. 2: 40-43.
  2. Мазина Н. К., Мазин П. В., Хазанов В. А. Некоторые теоретические и прикладные аспекты системного действия регуляторов энергетического обмена. В кн.: Регуляторы энергетического обмена. Клинико-фармакологические аспекты. Матер. V Всероссийского симпозиума. XIII Российский нац. конгресс "Человек и лекарство". М.; Томск, 2006: 93-101.
  3. Маликов В. Е., Сукаян Г. В., Юситов А. С. Способы кардиопротекции при хирургической реваскуляризации миокарда. М.: Изд-во НЦССХ им. А. Н. Бакулева РАМН; 2005. 56.
  4. Пархоменко А. Н., Иркин О. И., Кожунов С. Н. Возможности фармакологической защиты миокарда при синдроме ишемии-реперфузии в эксперименте и клинической практике. Лiкi Украiни 2002; 7-8: 2-11.
  5. Сидоренко Г. И., Комиссарова С. М. и др. Опыт применения актопротектора реамберина в клинике кардиохирургии. Клин. фармакол. и тер. 2007; 3: 39-43.
  6. Шабалин А. В., Никитин Ю. П. Защита кардиомиоцита. Современное состояние и перспективы. Кардиология 1999; 78 (3): 4-10.
  7. Beller G. A. Diagnostic accuracy of thallium-201 myocardial perfusion imaging. Circulation 1991; 84 (3): 11-16.
  8. Charney R., Schwinger M. E., Chun J. et al. Dobutamin echocardiography and resting-redistribution Thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am.Heart J. 1994; 128: 864- 869.
  9. Gibson R. S., Watson D. D., Taylor G. J. Prospective assessment of regional myocardial perfusion befor and after coronary evascularization surgery by quantitative thallium-201 scintigraphy. J. Am. Coll. Cardiol. 1983; 1: 804-815.

Statistics

Views

Abstract - 66

Cited-By


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies